Table no: 18
Invetlab has designed innovative HIRAVET probiotic as highly efficient alternative to use of antibiotics in prevention and treatment of intestinal infections in livestock production. HIRAVET has a specific antimicrobial effect with unique spectrum of activity on clinically relevant pathogens such as Escherichia coli, Salmonella sp., and Clostridium sp. HIRAVET probiotic has a positive effect on colonization of gut microbiota in the first days after birth, as well as when gut microbiota is disturbed, and bursts immunity in newborns. The efficacy of HIRAVET have been proven in farm trials.
To reach the EU market, we are looking for strategic partners in Hungary, Romania and Croatia to register HIRAVET probiotic for EU market. The long-term goal is to expand to the global market by partnering with globally positioned feed producers. We are looking for €1 million investment for 10% ownership share, and a global distributor.